Promedius raises 21.5 billion won in funding, doubling its fundraising target, with participation from Starset Investment, Woori Venture Partners, and more.
Promedius recently succeeded in raising 21.5 billion won in funding, exceeding their original target. The latest round saw participation from existing and new investors, including Daewoong Pharmaceutical and Naver. Founded in 2019, Promedius is developing AI technology for early detection of aging and metabolic diseases. This funding will enhance their innovative efforts.
Who to call at Promedius, and when
A new round usually means Promedius is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Promedius raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Promedius, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Promedius. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Promedius
Location
Seoul, South Korea
About
Promedius is a company founded in 2019 by researchers from Asan Medical Center. It focuses on developing technology that uses artificial intelligence (AI) to detect aging and metabolic diseases at an early stage. The company's cumulative funding now exceeds 35 billion won, with the latest round raising 21.5 billion won. Promedius aims to enhance early diagnosis and intervention in age-related and metabolic health issues.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Promedius raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.